Rigel Pharmaceuticals Inc (RIGL)
Financing Cash Flow
-$11.70M
Quarterly · Period ending: · USD
RIGL Financing Cash Flow
Latest reported-$11.70Mperiod ending
Latest reported-$11.70Mperiod ending
RIGL Quarterly Cash from Financing (-$269.00K → -$11.70M)
Quarterly financing cash flow
High-resolution chart · PNG
RIGL financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| -11,701,000 | |
| -10,919,000 | |
| -4,572,000 | |
| 4,271,000 | |
| 418,000 | |
| 484,000 | |
| 1,465,000 | |
| -9,842,000 | |
| -752,000 | |
| -2,512,000 | |
| 486,000 | |
| -869,000 | |
| -373,000 | |
| 19,123,000 | |
| -2,096,000 | |
| 5,511,000 | |
| -5,662,000 | |
| 8,797,000 | |
| 1,085,000 | |
| 274,000 | |
| 59,219,000 | |
| 2,097,000 | |
| 667,000 | |
| 52,000 | |
| 10,516,000 | |
| 1,336,000 | |
| 694,000 | |
| 9,799,000 | |
| 856,000 | |
| 16,000 | |
| 1,099,000 | |
| 635,000 | |
| 68,149,000 | |
| 2,011,000 | |
| 67,366,000 | |
| 3,337,000 | |
| 3,561,000 | |
| 43,424,000 | |
| 2,035,000 | |
| 13,182,000 | |
| 9,963,000 | |
| 4,000 | |
| 5,926,000 | |
| 98,000 | |
| 1,012,000 | |
| 17,000 | |
| 480,000 | |
| 5,000 | |
| 661,000 | |
| 24,000 | |
| 229,000 | |
| 0 | |
| 822,000 | |
| 0 | |
| 136,525,000 | |
| 1,196,000 | |
| 885,000 | |
| 488,000 | |
| 769,000 | |
| 21,000 | |
| 141,388,000 | |
| -199,000 | |
| 506,000 | |
| -34,000 | |
| 585,000 | |
| -237,000 | |
| 576,000 | |
| 101,571,000 | |
| 346,000 | |
| -338,000 | |
| 1,581,000 | |
| 447,000 | |
| 1,563,000 | |
| 128,399,000 | |
| 4,153,000 | |
| -217,000 | |
| 52,819,000 | |
| 21,000 | |
| 472,000 | |
| 925,000 | |
| 729,000 | |
| 710,000 | |
| 16,046,000 | |
| 81,543,000 | |
| 371,000 | |
| 5,645,000 | |
| 5,789,000 | |
| 1,122,000 | |
| -53,000 | |
| 57,973,000 | |
| -289,000 | |
| 8,485,000 | |
| 44,993,000 | |
| -357,000 | |
| -894,000 | |
| -462,000 | |
| 587,000 | |
| 30,853,000 | |
| -290,000 | |
| -659,000 |